Search

Your search keyword '"De La Rosa, F."' showing total 421 results

Search Constraints

Start Over You searched for: Author "De La Rosa, F." Remove constraint Author: "De La Rosa, F."
421 results on '"De La Rosa, F."'

Search Results

2. A Solve-RD ClinVar-based reanalysis of 1522 index cases from ERN-ITHACA reveals common pitfalls and misinterpretations in exome sequencing

3. Frequency of Health Care Resource Utilization and Direct Medical Costs Associated with Psoriatic Arthritis in a Rheumatic Care Center in Colombia

4. Twist exome capture allows for lower average sequence coverage in clinical exome sequencing

5. A Solve-RD ClinVar-based reanalysis of 1522 index cases from ERN-ITHACA reveals common pitfalls and misinterpretations in exome sequencing

6. Clinical, genetic, epidemiologic, evolutionary, and functional delineation of TSPEAR-related autosomal recessive ectodermal dysplasia 14

7. A Solve-RD ClinVar-based reanalysis of 1522 index cases from ERN-ITHACA reveals common pitfalls and misinterpretations in exome sequencing

8. Twist exome capture allows for lower average sequence coverage in clinical exome sequencing

10. Preguntó (que) si qué quería: si como operador interrogativo en español vernáculo

11. Solving unsolved rare neurological diseases-a Solve-RD viewpoint

15. Querying a Polynomial Object-Relational Constraint Database in Model-Based Diagnosis

16. Analysis and Visualization of the DX Community with Information Extracted from the Web

19. Correction to: Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases

20. Solving patients with rare diseases through programmatic reanalysis of genome-phenome data

21. Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases

22. Correction: Solving unsolved rare neurological diseases—a Solve-RD viewpoint (European Journal of Human Genetics, (2021), 29, 9, (1332-1336), 10.1038/s41431-021-00901-1)

26. Correction: Solving unsolved rare neurological diseases : A Solve-RD viewpoint

27. Evaluation of the antiviral effect of chlorine dioxide (ClO2) using a vertebrate model inoculated with avian coronavirus

36. PIN13 ESTIMATING THE IMPACT OF A GENDER-NEUTRAL QUADRIVALENT HUMAN PAPILLOMAVIRUS VACCINATION PROGRAM IN ALL HPV 6/11/16/18 -RELATED DISEASES IN COLOMBIA

37. PCV61 EFFECTIVENESS OF A CARDIOVASCULAR RISK MANAGEMENT PROGRAM IN REDUCING THE PROBABILITY OF PREMATURE DEATH DUE TO CARDIOVASCULAR EVENTS IN THE COLOMBIAN CARIBBEAN REGION

38. PCV52 EFFECTIVENESS OF A CARDIOVASCULAR DISEASE PREVENTION PROGRAM IN THE CONTROL OF CARDIOVASCULAR RISK FACTORS IN A LOW-INCOME POPULATION FROM THE CARIBBEAN REGION OF COLOMBIA

40. PRS50 HEALTH CARE COSTS OF COPD IN COLOMBIA

42. PCV56 COMPARISON OF THE FRAMINGHAM, PROCAM AND MODIFIED FRAMINGHAM RISK SCORES FOR PREDICTING CARDIOVASCULAR EVENTS IN A COHORT FROM A CARDIOVASCULAR PREVENTION PROGRAM IN THE CARIBBEAN REGION OF COLOMBIA

43. PCV53 EFFECTIVENESS OF A CARDIOVASCULAR RISK MANAGEMENT PROGRAM IN THE INCIDENCE OF CARDIOVASCULAR EVENTS IN A LOW-INCOME POPULATION FROM THE CARIBBEAN REGION OF COLOMBIA

44. LUMBAR HYPERLORDOSIS PREVENTION AND ITS ASSOCIATED PATHOLOGIES IN RHYTHMIC GYMNASTICS.

49. PIN9 PUBLIC HEALTH AND ECONOMIC IMPACT OF A GENDER-NEUTRAL QUADRIVALENT HUMAN PAPILLOMAVIRUS VACCINATION PROGRAM IN COLOMBIA

50. PIN28 COST-EFFECTIVENESS OF QUADRIVALENT (6,11,16,18) HPV VACCINATION IN 9 TO 10 YEARS OLD FEMALES AT DIFFERENT COVERAGE RATES IN COLOMBIA

Catalog

Books, media, physical & digital resources